Nike faces high-stakes earnings test under Elliott Hill

Wall Street anticipates earnings of 43 cents per share on revenue of $11.32 billion, according to LSEG analyst surveys. The retailer remains under intense pressure to prove its turnaround strategy is gaining traction, particularly after North American revenue missed expectations last quarter. China, once a primary engine for growth, presents a significant hurdle following a 12% drop in sales during the previous reporting period.

Leadership transitions continue to define this volatile period for the brand, with former Pfizer executive David Denton stepping into the CFO role in August. While the company projects a slightly positive gross margin compared to the prior year, macroeconomic headwinds—including persistent inflation and geopolitical instability—have curbed consumer spending. Bank of America recently downgraded the stock to underperform, citing rising risks and a category-wide slowdown, signaling that the path to recovery remains steep for the athletic giant.